DrugPatentWatch Database Preview

Details for Patent: 9,192,616

« Back to Dashboard

Which drugs does patent 9,192,616 protect, and when does it expire?

Patent 9,192,616 protects GIAZO and is included in one NDA.

This patent has thirty-four patent family members in eleven countries.

Summary for Patent: 9,192,616

Title:	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Abstract:	A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
Inventor(s):	Johnson; Lorin (Palo Alto, CA)
Assignee:	Salix Pharmaceuticals, Inc. (Raleigh, NC)
Application Number:	13/439,594
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 9,192,616

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Valeant Pharms Intl	GIAZO	balsalazide disodium	TABLET;ORAL	022205-001	Feb 3, 2012	AB	RX	Yes	Yes						TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS

Non-Orange Book US Patents Family Members for Patent 9,192,616

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,452,872	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
8,921,344	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
7,625,884	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives

International Family Members for US Patent 9,192,616

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
New Zealand	603744
New Zealand	593132
New Zealand	565974
Mexico	2009004826